Seladin-1 and testicular germ cell tumours

New insights into cisplatin responsiveness

Francesca Nuti, Paola Luciani, Eliana Marinari, Edit Erdei, M. Bak, Cristiana Deledda, Fabiana Rosati, Benedetta Mazzinghi, Giovanna Danza, Hans Stoop, Leendert H J Looijenga, Alessandro Peri, Mario Serio, Csilla Krausz

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The molecular basis for the exquisite sensitivity of testicular germ cell tumours of adolescents and adults (TGCTs), ie seminomas and non-seminomatous germ cell tumours, to chemo/radiotherapy has not been fully clarified so far. It has been suggested that it may be dependent on factors involved in the regulation of apoptosis. Seladin-1 is a multi-functional protein involved in various biological processes, including apoptosis. The aim of our study was to assess the expression of seladin-1 in different histological types of TGCTs, known to have varying treatment sensitivity, in order to establish whether this protein may influence cisplatin responsiveness in vitro. Seladin-1 expression levels, both at the mRNA and at the protein level, were higher in the adjacent normal parenchyma than in the pathological counterparts. In tumoural tissues, the level of expression differed among TGCT histological types. The highest tumour-expression level was found in teratoma, whereas the lowest was detected in seminoma, corresponding to the different chemo/and radiosensitivities of these tumour types. In common with other cancers, in TGCT-derived cell lines seladin-1 showed anti-apoptotic properties through inhibition of caspase-3 activation. We confirmed our results using a non-seminomatous cell line model (NT2) before and after differentiation with retinoic acid. Significantly higher seladin-1 expression was observed in the differentiated derivatives (teratoma) and an inverse relationship was found between seladin-1 expression and the amount of cleaved caspase-3. Seladin-1 silencing or overexpression in this cell line supports involvement of seladin-1 in cisplatin responsiveness. Seladin-1 silencing was associated with greater cisplatin responsiveness demonstrated by decreased cell viability and increased expression of apoptotic markers. In contrast, overexpression of seladin-1 was associated with a higher survival rate and a clear anti-apoptotic effect. In conclusion, we have demonstrated for the first time an important role for seladin-1 in the biology of TGCTs and provided new insights into cisplatin responsiveness of these tumours.

Original languageEnglish
Pages (from-to)491-500
Number of pages10
JournalJournal of Pathology
Volume219
Issue number4
DOIs
Publication statusPublished - Dec 2009

Fingerprint

Cisplatin
Seminoma
Teratoma
Cell Line
Caspase 3
Neoplasms
Apoptosis
Biological Phenomena
Proteins
Radiation Tolerance
Tretinoin
Cell Survival
Radiotherapy
Messenger RNA
Testicular Germ Cell Tumor 1
Therapeutics

Keywords

  • Apoptosis
  • Cisplatin
  • Male infertility
  • Seladin-1
  • Testicular cancer
  • TGCT

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Nuti, F., Luciani, P., Marinari, E., Erdei, E., Bak, M., Deledda, C., ... Krausz, C. (2009). Seladin-1 and testicular germ cell tumours: New insights into cisplatin responsiveness. Journal of Pathology, 219(4), 491-500. https://doi.org/10.1002/path.2622

Seladin-1 and testicular germ cell tumours : New insights into cisplatin responsiveness. / Nuti, Francesca; Luciani, Paola; Marinari, Eliana; Erdei, Edit; Bak, M.; Deledda, Cristiana; Rosati, Fabiana; Mazzinghi, Benedetta; Danza, Giovanna; Stoop, Hans; Looijenga, Leendert H J; Peri, Alessandro; Serio, Mario; Krausz, Csilla.

In: Journal of Pathology, Vol. 219, No. 4, 12.2009, p. 491-500.

Research output: Contribution to journalArticle

Nuti, F, Luciani, P, Marinari, E, Erdei, E, Bak, M, Deledda, C, Rosati, F, Mazzinghi, B, Danza, G, Stoop, H, Looijenga, LHJ, Peri, A, Serio, M & Krausz, C 2009, 'Seladin-1 and testicular germ cell tumours: New insights into cisplatin responsiveness', Journal of Pathology, vol. 219, no. 4, pp. 491-500. https://doi.org/10.1002/path.2622
Nuti, Francesca ; Luciani, Paola ; Marinari, Eliana ; Erdei, Edit ; Bak, M. ; Deledda, Cristiana ; Rosati, Fabiana ; Mazzinghi, Benedetta ; Danza, Giovanna ; Stoop, Hans ; Looijenga, Leendert H J ; Peri, Alessandro ; Serio, Mario ; Krausz, Csilla. / Seladin-1 and testicular germ cell tumours : New insights into cisplatin responsiveness. In: Journal of Pathology. 2009 ; Vol. 219, No. 4. pp. 491-500.
@article{c790bfbec1ab4407bd7ed57eecd94c4f,
title = "Seladin-1 and testicular germ cell tumours: New insights into cisplatin responsiveness",
abstract = "The molecular basis for the exquisite sensitivity of testicular germ cell tumours of adolescents and adults (TGCTs), ie seminomas and non-seminomatous germ cell tumours, to chemo/radiotherapy has not been fully clarified so far. It has been suggested that it may be dependent on factors involved in the regulation of apoptosis. Seladin-1 is a multi-functional protein involved in various biological processes, including apoptosis. The aim of our study was to assess the expression of seladin-1 in different histological types of TGCTs, known to have varying treatment sensitivity, in order to establish whether this protein may influence cisplatin responsiveness in vitro. Seladin-1 expression levels, both at the mRNA and at the protein level, were higher in the adjacent normal parenchyma than in the pathological counterparts. In tumoural tissues, the level of expression differed among TGCT histological types. The highest tumour-expression level was found in teratoma, whereas the lowest was detected in seminoma, corresponding to the different chemo/and radiosensitivities of these tumour types. In common with other cancers, in TGCT-derived cell lines seladin-1 showed anti-apoptotic properties through inhibition of caspase-3 activation. We confirmed our results using a non-seminomatous cell line model (NT2) before and after differentiation with retinoic acid. Significantly higher seladin-1 expression was observed in the differentiated derivatives (teratoma) and an inverse relationship was found between seladin-1 expression and the amount of cleaved caspase-3. Seladin-1 silencing or overexpression in this cell line supports involvement of seladin-1 in cisplatin responsiveness. Seladin-1 silencing was associated with greater cisplatin responsiveness demonstrated by decreased cell viability and increased expression of apoptotic markers. In contrast, overexpression of seladin-1 was associated with a higher survival rate and a clear anti-apoptotic effect. In conclusion, we have demonstrated for the first time an important role for seladin-1 in the biology of TGCTs and provided new insights into cisplatin responsiveness of these tumours.",
keywords = "Apoptosis, Cisplatin, Male infertility, Seladin-1, Testicular cancer, TGCT",
author = "Francesca Nuti and Paola Luciani and Eliana Marinari and Edit Erdei and M. Bak and Cristiana Deledda and Fabiana Rosati and Benedetta Mazzinghi and Giovanna Danza and Hans Stoop and Looijenga, {Leendert H J} and Alessandro Peri and Mario Serio and Csilla Krausz",
year = "2009",
month = "12",
doi = "10.1002/path.2622",
language = "English",
volume = "219",
pages = "491--500",
journal = "Journal of Pathology",
issn = "0022-3417",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - Seladin-1 and testicular germ cell tumours

T2 - New insights into cisplatin responsiveness

AU - Nuti, Francesca

AU - Luciani, Paola

AU - Marinari, Eliana

AU - Erdei, Edit

AU - Bak, M.

AU - Deledda, Cristiana

AU - Rosati, Fabiana

AU - Mazzinghi, Benedetta

AU - Danza, Giovanna

AU - Stoop, Hans

AU - Looijenga, Leendert H J

AU - Peri, Alessandro

AU - Serio, Mario

AU - Krausz, Csilla

PY - 2009/12

Y1 - 2009/12

N2 - The molecular basis for the exquisite sensitivity of testicular germ cell tumours of adolescents and adults (TGCTs), ie seminomas and non-seminomatous germ cell tumours, to chemo/radiotherapy has not been fully clarified so far. It has been suggested that it may be dependent on factors involved in the regulation of apoptosis. Seladin-1 is a multi-functional protein involved in various biological processes, including apoptosis. The aim of our study was to assess the expression of seladin-1 in different histological types of TGCTs, known to have varying treatment sensitivity, in order to establish whether this protein may influence cisplatin responsiveness in vitro. Seladin-1 expression levels, both at the mRNA and at the protein level, were higher in the adjacent normal parenchyma than in the pathological counterparts. In tumoural tissues, the level of expression differed among TGCT histological types. The highest tumour-expression level was found in teratoma, whereas the lowest was detected in seminoma, corresponding to the different chemo/and radiosensitivities of these tumour types. In common with other cancers, in TGCT-derived cell lines seladin-1 showed anti-apoptotic properties through inhibition of caspase-3 activation. We confirmed our results using a non-seminomatous cell line model (NT2) before and after differentiation with retinoic acid. Significantly higher seladin-1 expression was observed in the differentiated derivatives (teratoma) and an inverse relationship was found between seladin-1 expression and the amount of cleaved caspase-3. Seladin-1 silencing or overexpression in this cell line supports involvement of seladin-1 in cisplatin responsiveness. Seladin-1 silencing was associated with greater cisplatin responsiveness demonstrated by decreased cell viability and increased expression of apoptotic markers. In contrast, overexpression of seladin-1 was associated with a higher survival rate and a clear anti-apoptotic effect. In conclusion, we have demonstrated for the first time an important role for seladin-1 in the biology of TGCTs and provided new insights into cisplatin responsiveness of these tumours.

AB - The molecular basis for the exquisite sensitivity of testicular germ cell tumours of adolescents and adults (TGCTs), ie seminomas and non-seminomatous germ cell tumours, to chemo/radiotherapy has not been fully clarified so far. It has been suggested that it may be dependent on factors involved in the regulation of apoptosis. Seladin-1 is a multi-functional protein involved in various biological processes, including apoptosis. The aim of our study was to assess the expression of seladin-1 in different histological types of TGCTs, known to have varying treatment sensitivity, in order to establish whether this protein may influence cisplatin responsiveness in vitro. Seladin-1 expression levels, both at the mRNA and at the protein level, were higher in the adjacent normal parenchyma than in the pathological counterparts. In tumoural tissues, the level of expression differed among TGCT histological types. The highest tumour-expression level was found in teratoma, whereas the lowest was detected in seminoma, corresponding to the different chemo/and radiosensitivities of these tumour types. In common with other cancers, in TGCT-derived cell lines seladin-1 showed anti-apoptotic properties through inhibition of caspase-3 activation. We confirmed our results using a non-seminomatous cell line model (NT2) before and after differentiation with retinoic acid. Significantly higher seladin-1 expression was observed in the differentiated derivatives (teratoma) and an inverse relationship was found between seladin-1 expression and the amount of cleaved caspase-3. Seladin-1 silencing or overexpression in this cell line supports involvement of seladin-1 in cisplatin responsiveness. Seladin-1 silencing was associated with greater cisplatin responsiveness demonstrated by decreased cell viability and increased expression of apoptotic markers. In contrast, overexpression of seladin-1 was associated with a higher survival rate and a clear anti-apoptotic effect. In conclusion, we have demonstrated for the first time an important role for seladin-1 in the biology of TGCTs and provided new insights into cisplatin responsiveness of these tumours.

KW - Apoptosis

KW - Cisplatin

KW - Male infertility

KW - Seladin-1

KW - Testicular cancer

KW - TGCT

UR - http://www.scopus.com/inward/record.url?scp=72249096230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72249096230&partnerID=8YFLogxK

U2 - 10.1002/path.2622

DO - 10.1002/path.2622

M3 - Article

VL - 219

SP - 491

EP - 500

JO - Journal of Pathology

JF - Journal of Pathology

SN - 0022-3417

IS - 4

ER -